This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hinuma, Y. Articles by Grace, J. T. Search for Related Content PubMed PubMed Citation Articles by Hinuma, Y. Articles by Grace, J. T., Jr.

 Previous Article  |  Next Article 

J Virol. 1967 October; 1(5): 1045-1051
Copyright © 1967 American Society for Microbiology. All Rights Reserved.

Immunofluorescence and Herpes-Type Virus Particles in the P3HR-1 Burkitt Lymphoma Cell Line

¹ Viral Oncology Section, Roswell Park Memorial Institute, Buffalo, New York 14203

ABSTRACT

A subline of the P3 (Jijoye) Burkitt lymphoma cell line, designated P3HR-1, initially contained 1 to 5% of cells which were positive by indirect immunofluorescence with selected human sera. After 4 months of propagation, this cell line regularly showed 15 to 40% reactive cells. Antigen(s) in the cell line which was reactive by immunofluorescence was similar or identical to that found in several other Burkitt tumor cell lines in previous studies. When the cells were incubated at 35 or 32 C for 9 to 15 days without refeeding, more than 50% of the cells became immunofluorescence-positive. Thirteen different cultures of P3HR-1 cells, which contained up to 75% immunofluorescence-positive cells, were thin-sectioned and examined by electron microscopy. The percentage of cells containing herpes-type virus particles in the cultures varied from <3 to 78%. There was generally a good correlation between the number of immunofluorescent cells and the number of cells containing virus particles. The number of virus particles per cell section ranged from 1 to more than 100. These results strongly support the hypothesis that the immunofluorescent antigen is related to the presence of the herpes-type virus particle in the cells.

This article has been cited by other articles:

• Jansson, A., Johansson, P., Li, S., Rymo, L. (2007). Activity of the LMP1 gene promoter in Epstein-Barr virus-transformed cell lines is modulated by sequence variations in the promoter-proximal CRE site. J. Gen. Virol. 88: 1887-1894 [Abstract] [Full Text]  
• Kis, L. L., Takahara, M., Nagy, N., Klein, G., Klein, E. (2006). IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines. Blood 107: 2928-2935 [Abstract] [Full Text]  
• Zeng, M.-S., Li, D.-J., Liu, Q.-L., Song, L.-B., Li, M.-Z., Zhang, R.-H., Yu, X.-J., Wang, H.-M., Ernberg, I., Zeng, Y.-X. (2005). Genomic Sequence Analysis of Epstein-Barr Virus Strain GD1 from a Nasopharyngeal Carcinoma Patient. J. Virol. 79: 15323-15330 [Abstract] [Full Text]  
• Wang, J.-T., Yang, P.-W., Lee, C.-P., Han, C.-H., Tsai, C.-H., Chen, M.-R. (2005). Detection of Epstein-Barr virus BGLF4 protein kinase in virus replication compartments and virus particles. J. Gen. Virol. 86: 3215-3225 [Abstract] [Full Text]  
• Gonnella, R., Farina, A., Santarelli, R., Raffa, S., Feederle, R., Bei, R., Granato, M., Modesti, A., Frati, L., Delecluse, H.-J., Torrisi, M. R., Angeloni, A., Faggioni, A. (2005). Characterization and Intracellular Localization of the Epstein-Barr Virus Protein BFLF2: Interactions with BFRF1 and with the Nuclear Lamina. J. Virol. 79: 3713-3727 [Abstract] [Full Text]  
• Schaadt, E., Baier, B., Mautner, J., Bornkamm, G. W., Adler, B. (2005). Epstein-Barr virus latent membrane protein 2A mimics B-cell receptor-dependent virus reactivation. J. Gen. Virol. 86: 551-559 [Abstract] [Full Text]  
• Farina, A., Santarelli, R., Gonnella, R., Bei, R., Muraro, R., Cardinali, G., Uccini, S., Ragona, G., Frati, L., Faggioni, A., Angeloni, A. (2000). The BFRF1 Gene of Epstein-Barr Virus Encodes a Novel Protein. J. Virol. 74: 3235-3244 [Abstract] [Full Text]  
• Paulson, E. J., Speck, S. H. (1999). Differential Methylation of Epstein-Barr Virus Latency Promoters Facilitates Viral Persistence in Healthy Seropositive Individuals. J. Virol. 73: 9959-9968 [Abstract] [Full Text]  
• Lagenaur, L. A., Palefsky, J. M. (1999). Regulation of Epstein-Barr Virus Promoters in Oral Epithelial Cells and Lymphocytes. J. Virol. 73: 6566-6572 [Abstract] [Full Text]  
• Yoshizaki, T., Sato, H., Furukawa, M., Pagano, J. S. (1998). The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc. Natl. Acad. Sci. USA 95: 3621-3626 [Abstract] [Full Text]  
• Ono, S. J., Song, Z. (1995). Mapping of the Interaction Site of the Defective Transcription Factor in the Class II Major Histocompatibility Complex Mutant Cell Line Clone-13 to the Divergent X2-Box. J. Biol. Chem. 270: 6396-6402 [Abstract] [Full Text]  
• Nelson-Rees, W., Daniels, D., Flandermeyer, R. (1981). Cross-contamination of cells in culture. Science 212: 446-452 [Abstract]  
• Miller, G, Grogan, E, Heston, L, Robinson, J, Smith, D (1981). Epstein-Barr viral DNA: infectivity for human placental cells. Science 212: 452-455 [Abstract]  
• Probert, M., Epstein, M. A. (1972). Morphological Transformation in vitro of Human Fibroblasts by Epstein-Barr Virus: Preliminary Observations. Science 175: 202-203 [Abstract]  
• Henle, W., Henle, G., Zajac, B. A., Pearson, G., Waubke, R., Scriba, M. (1970). Differential Reactivity of Human Serums with Early Antigens Induced by Epstein-Barr Virus. Science 169: 188-190 [Abstract]  
• Adler, B., Schaadt, E., Kempkes, B., Zimber-Strobl, U., Baier, B., Bornkamm, G. W. (2002). Control of Epstein-Barr virus reactivation by activated CD40 and viral latent membrane protein 1. Proc. Natl. Acad. Sci. USA 99: 437-442 [Abstract] [Full Text]